Live Breaking News & Updates on Alnylam Pharmaceuticals Quarter One

Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75. ....

Rhode Island , United States , Tolga Tanguler , Raymond James , Maury Raycroft , Pushkal Garg , Gary Nachman , Jeff Poulton , Christine Lindenboom , Paul Matteis , David Lebowitz , Yvonne Greenstreet , Alnylam Pharmaceuticals Quarter , Corporate Communications At Alnylam , Alnylam Pharmaceuticals Inc , Alnylam Pharmaceuticals , Call Transcript May , Alnylam Pharmaceuticals Quarter One , Senior Vice President , Investor Relations , Corporate Communications , Chief Executive Officer , Chief Commercial Officer , Chief Medical Officer , Chief Financial , Safe Harbor ,